Petco Health and Wellness Company, Inc. (WOOF) Securities Class Action Lawsuit Update [August 12, 2025]

Introduction to Petco Securities Class Action Lawsuit

Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) got hit with a securities fraud class action lawsuit. It’s for investors who bought stock between January 14, 2021, and June 5, 2025. The lawsuit claims Petco’s execs lied about riding pandemic pet adoption waves and a pivot toward pet-health conscious consumers. They sold growth like a shiny new leash. Reality bit hard. Stocks sank. Investors lost millions. Shareholders are clawing back losses, raw as a chewed-up bone. 

Petco Securities Lawsuit Case Details

Caption: Spurbeck v. Petco Health and Wellness Company, Inc., et al. 
Case No.: 3:25-cv-01667-BEN-VET 
Jurisdiction: United States District Court, Southern District of California 
Filed on: June 30, 2025 

Petco Health and Wellness Company, Inc. (WOOF) Company Profile

Petco sells pet products and service. It operates a Web site and physical stores and online platforms push consumables and gear.  

Class Period 

January 14, 2021–June 5, 2025 

WOOF shareholders who acquired Petco securities during the class period might be eligible to join the Petco Health and Wellness class action lawsuit.  

Allegations in the Petco Health and Wellness Company, Inc. (WOOF) Lawsuit

The lawsuit pins Petco and execs Joel D. Anderson, R. Michael Mohan, Ronald V. Coughlin, Jr., Sabrina Simmons, Brian LaRose, and Michael Nuzzo for securities law violations. 

From 2021-2024, Petco touted stellar growth and resilient, growing demand.  On January 14, 2021, Petco’s Q4 2020 earnings reported 11% comparable sales growth, with Coughlin citing “pet humanization” trends and sustained adoption.  The Q4 2020 Form 10-K claimed Petco’s health focus set it apart from competitors.  On May 20, 2021, Q1 2021 earnings showed 27% comp sales growth, with Coughlin touting premium pet food demand.  On August 19, 2021, Q2 earnings and a call pushed “sustainable” growth, with Mohan claiming strong margins. 

On November 18, 2021, Q3 earnings reported 15% comp sales growth, with Coughlin saying health trends were “here to stay.” The 2021 Form 10-K emphasized premiumization. On March 8, 2022, Q4 2021 earnings projected 2022 comp sales growth at 3–5%, with Nuzzo citing supply chain fixes.  On August 10, 2023, Q2 2023 earnings claimed 3.4% comp sales growth, with LaRose noting digital strength. On March 13, 2024, Q4 2023 earnings forecasted $6.1–$6.3 billion for 2024, with Mohan hyping “resilient demand.”  

It didn’t hold. Plaintiffs say Defendants downplayed fading pandemic demand, supply chain snags, and weaker health trends.  Their growth story unraveled like an overused dog toy.  The filed complaint alleges Petco’s failure to disclose these risks violated federal securities laws, including Sections 10(b) and 20(a) of the Securities Exchange Act. Plaintiffs’ legal claims state that Petco’s statements about comparable sales and premiumization were materially false and misleading, lacking a reasonable basis, and harmed investors. 

The Truth Emerges

On May 22, 2024, Petco’s Q1 2024 earnings missed revenue by $30 million, posting a $24.1 million net loss.  On June 5, 2025, Q1 2025 results reported an 8.5% comp sales drop and a $47 million loss, scrapping 2025 guidance due to “macro softness” and supply issues.  Petco’s health-focused hype faded like a worn-out chew toy. 

Market Reaction

Petco’s stock stung like a flea bite. On May 23, 2024, it fell 14.29% to $1.80, down $0.30. On June 6, 2025, it dropped 18.75% to $1.30, down another $0.30. Investors lost millions.  

Next Steps 

• Submissions for lead plaintiff are due August 29, 2025.  

• The Court will issue its order for lead plaintiff and counsel in the weeks after submissions are due.    

• The Court will then consider motion for class certification.     

• The Court will later consider a Motion to Dismiss.    

To learn if you are eligible for recovery under the Petco securities class action lawsuit, visit the case submission page here.

 Disclaimer: This shareholder alert is for informational purposes only and does not constitute legal advice. Consult a qualified attorney for personalized guidance. No specific outcomes are guaranteed.